Vancomycin-resistant enterococci in Canada: Results from the Canadian nosocomial infection surveillance program, 1999-2005

Marianna Ofner-Agostini, B. Lynn Johnston, Andrew E. Simor, John Embil, Anne Matlow, Michael Mulvey, Debbie Ormiston, John Conly

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

27 Citas (Scopus)

Resumen

Surveillance for vancomycin-resistant enterococci (VRE) in sentinel Canadian hospitals has been conducted since 1999. From 1999 to 2005, the rate of VRE detection increased from 0.37 to 1.32 cases per 1,000 patients admitted, and the rate of VRE infection increased from 0.02 to 0.05 cases per 1,000 patients admitted. Thirty-three percent of all patients with VRE detected that were reported during 1999-2005 were identified in 2005, with increases seen in all regions of Canada. Although the incidence rate of VRE carriage in Canada is increasing, it remains very low.

Idioma originalEnglish
Páginas (desde-hasta)271-274
Número de páginas4
PublicaciónInfection Control and Hospital Epidemiology
Volumen29
N.º3
DOI
EstadoPublished - mar. 2008
Publicado de forma externa

ASJC Scopus Subject Areas

  • Epidemiology
  • Microbiology (medical)
  • Infectious Diseases

Huella

Profundice en los temas de investigación de 'Vancomycin-resistant enterococci in Canada: Results from the Canadian nosocomial infection surveillance program, 1999-2005'. En conjunto forman una huella única.

Citar esto